Likely as a result of this multifunctional character, CD26 is associated with a high level of clinical aggressiveness in some tumours but a lower level in others (Iwata and Morimoto, 1999; Kajiyama et al, 2002; Havre et al, 2008). Here, DPP4 is linked to neoplasm.